Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)
NCT06425055
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Alport Syndrome
Interventions
DRUG:
Vonafexor
Sponsor
Enyo Pharma